UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer

The American journal of gastroenterology, 2011-06, Vol.106 (6), p.1110-1118

2011

Link zum Volltext

Verfügbarkeit prüfen

Soluble MICA in malignant diseases

International journal of cancer, 2006-02, Vol.118 (3), p.684-687

2006

Link zum Volltext

Verfügbarkeit prüfen

Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian Cancer

Cancer epidemiology, biomarkers & prevention, 2009-04, Vol.18 (4), p.1127-1133

2009

Link zum Volltext

Verfügbarkeit prüfen

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer

BMC cancer, 2014-04, Vol.14 (1), p.245-245, Article 245

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort

PloS one, 2012-10, Vol.7 (10), p.e45066

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy

Tumor biology, 2012-12, Vol.33 (6), p.2401-2409

2012

Link zum Volltext

Verfügbarkeit prüfen

Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer

Clinical cancer research, 2006-12, Vol.12 (24), p.7347-7352

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of Circulating Nucleosomes in Cancer

Annals of the New York Academy of Sciences, 2008-08, Vol.1137 (1), p.180-189

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

BMC cancer, 2012-01, Vol.12 (1), p.5-5, Article 5

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients

Clinical cancer research, 2004-03, Vol.10 (5), p.1706-1716

2004

Link zum Volltext

Verfügbarkeit prüfen

OPG Is Regulated by β-Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer

Clinical cancer research, 2008-08, Vol.14 (15), p.4713-4718

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations

Tumor biology, 2005-01, Vol.26 (6), p.281-293

2005

Link zum Volltext

Verfügbarkeit prüfen

In memoriam of Rafael Molina (27 September 1955 - 26 July 2020)

Tumor biology, 2021-05, Vol.43 (1), p.97-98

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer

Clinical cancer research, 2004-09, Vol.10 (18), p.5981-5987

2004

Link zum Volltext

Verfügbarkeit prüfen

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2009-01, Vol.63 (1), p.128-135

2009

Link zum Volltext

Verfügbarkeit prüfen

Cell-free dna in serum and plasma : Comparison of ELISA and quantitative PCR

Clinical chemistry (Baltimore, Md.), 2005-08, Vol.51 (8), p.1544-1546

2005

Link zum Volltext

Verfügbarkeit prüfen

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

Clinical cancer research, 2010-02, Vol.16 (3), p.986-994

2010

Link zum Volltext

Verfügbarkeit prüfen

Pro-Gastrin-Releasing Peptide (ProGRP)-A Diagnostic Biomarker for Small-Cell Lung Cancer

Zhongguo fei ai za zhi, 2009-03, Vol.12 (3), p.183-186

Stieber, Petra

2009

Link zum Volltext

Verfügbarkeit prüfen

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

BMC cancer, 2011-05, Vol.11 (1), p.202-202, Article 202

2011

Link zum Volltext

Verfügbarkeit prüfen

Early and Specific Prediction of the Therapeutic Efficacy in Non-Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin-19 Fragments

Annals of the New York Academy of Sciences, 2006-09, Vol.1075 (1), p.244-257

2006

Link zum Volltext

Verfügbarkeit prüfen

Nucleosomal DNA Fragments in Autoimmune Diseases

Annals of the New York Academy of Sciences, 2006-09, Vol.1075 (1), p.318-327

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of circulating nucleosomes

Critical reviews in clinical laboratory sciences, 2009, Vol.46 (1), p.1-24

2009

Link zum Volltext

Verfügbarkeit prüfen

Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism

Anticancer research, 2007-07, Vol.27 (4A), p.2041-2045

2007

Link zum Volltext

Verfügbarkeit prüfen

Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer

Clinical cancer research, 2001-06, Vol.7 (6), p.1743-1749

2001

Link zum Volltext

Verfügbarkeit prüfen

Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments

BMC cancer, 2006-05, Vol.6 (1), p.143-143, Article 143

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 167

Suche als RSS-Feed

Aktive Filter

ThemaCea

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(152)
Japanisch
(18)
Deutsch
(18)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer

Soluble MICA in malignant diseases

Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian Cancer

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer

Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort

Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy

Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer

Clinical Relevance of Circulating Nucleosomes in Cancer

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients

OPG Is Regulated by β-Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer

Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations

In memoriam of Rafael Molina (27 September 1955 - 26 July 2020)

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

Cell-free dna in serum and plasma : Comparison of ELISA and quantitative PCR

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

Pro-Gastrin-Releasing Peptide (ProGRP)-A Diagnostic Biomarker for Small-Cell Lung Cancer

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

Early and Specific Prediction of the Therapeutic Efficacy in Non-Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin-19 Fragments

Nucleosomal DNA Fragments in Autoimmune Diseases

Clinical use of circulating nucleosomes

Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism

Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer

Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments

Aktive Filter

Suchergebnisse filtern